Neuroleptic malignant syndrome and serotonin syndrome.

Tormoehlen, Laura M; Rusyniak, Daniel E

Tormoehlen, Laura M; Rusyniak, Daniel E.

Afiliação

Tormoehlen LM; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, United States; Department of Emergency Medicine, Division of Medical Toxicology, Indiana University School of Medicine, Indianapolis, IN, United States.
Rusyniak DE; Department of Emergency Medicine, Division of Medical Toxicology, Indiana University School of Medicine, Indianapolis, IN, United States. Electronic address: drusynia@iu.edu.

Handb Clin Neurol ; 157: 663-675, 2018.

Article em En | MEDLINE | ID: mdl-30459031

Assuntos

Síndrome Maligna Neuroléptica/diagnóstico; Síndrome Maligna Neuroléptica/terapia; Síndrome da Serotonina/diagnóstico; Síndrome da Serotonina/terapia; Humanos

Palavras-chave

bromocriptine; cyproheptadine; dantrolene; hyperthermia; malignant catatonia; neuroleptic malignant syndrome; serotonin syndrome

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome da Serotonina / Síndrome Maligna Neuroléptica Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google